These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18662105)

  • 1. Prevention of invasive Candida infections in preterm infants: the time is now.
    Kaufman DA
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):393-9. PubMed ID: 18662105
    [No Abstract]   [Full Text] [Related]  

  • 2. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.
    Aydemir C; Oguz SS; Dizdar EA; Akar M; Sarikabadayi YU; Saygan S; Erdeve O; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F164-8. PubMed ID: 20659937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
    Kaufman DA
    Early Hum Dev; 2012 May; 88 Suppl 2():S45-9. PubMed ID: 22633513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic oral nystatin for preterm babies under 33 weeks' gestation decreases fungal colonisation and invasive fungaemia.
    Ganesan K; Harigopal S; Neal T; Yoxall CW
    Arch Dis Child Fetal Neonatal Ed; 2009 Jul; 94(4):F275-8. PubMed ID: 19036756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
    Manzoni P; Stolfi I; Pugni L; Decembrino L; Magnani C; Vetrano G; Tridapalli E; Corona G; Giovannozzi C; Farina D; Arisio R; Merletti F; Maule M; Mosca F; Pedicino R; Stronati M; Mostert M; Gomirato G; ;
    N Engl J Med; 2007 Jun; 356(24):2483-95. PubMed ID: 17568029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
    Parikh TB; Nanavati RN; Patankar CV; Rao S; Bisure K; Udani RH; Mehta P
    Indian Pediatr; 2007 Nov; 44(11):830-7. PubMed ID: 18057479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
    Bertini G; Perugi S; Dani C; Filippi L; Pratesi S; Rubaltelli FF
    J Pediatr; 2005 Aug; 147(2):162-5. PubMed ID: 16126042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the prevention of neonatal candidiasis.
    Leibovitz E
    Pediatr Neonatol; 2012 Apr; 53(2):83-9. PubMed ID: 22503254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants.
    Kaufman D
    Pediatrics; 2008 Nov; 122(5):1158-9; author reply 1159. PubMed ID: 18978001
    [No Abstract]   [Full Text] [Related]  

  • 12. Why prevent invasive Candida infections?
    Kaufman DA
    J Perinatol; 2008 Jun; 28(6):385-8. PubMed ID: 18511930
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.
    Kaufman DA; Gurka MJ; Hazen KC; Boyle R; Robinson M; Grossman LB
    Pediatr Infect Dis J; 2006 Aug; 25(8):733-7. PubMed ID: 16874174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole prophylaxis against fungal infection in preterm infants.
    Casalaz D
    N Engl J Med; 2002 Jun; 346(24):1913-4; author reply 1913-4. PubMed ID: 12066811
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
    Healy CM; Baker CJ; Zaccaria E; Campbell JR
    J Pediatr; 2005 Aug; 147(2):166-71. PubMed ID: 16126043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure.
    Weitkamp JH; Ozdas A; LaFleur B; Potts AL
    J Perinatol; 2008 Jun; 28(6):405-11. PubMed ID: 18185518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.